<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30886222</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Muscle contractility in spinobulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>4680</StartPage><MedlinePgn>4680</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4680</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-41240-y</ELocationID><Abstract><AbstractText>Spinobulbar muscular atrophy (SBMA) is caused by a trinucleotide repeat expansion in the androgen receptor gene on the X chromosome. There is a toxic effect of the mutant receptor on muscle and neurons resulting in muscle weakness and atrophy. The weakness can be explained by wasting due to loss of muscle cells, but it is unknown whether weakness also relates to poor muscle contractility of the remaining musculature. In this study, we investigated the muscle contractility in SBMA. We used stationary dynamometry and quantitative MRI to assess muscle strength and absolute and fat-free, cross-sectional areas. Specific muscle force (strength per cross-sectional area) and contractility (strength per fat-free cross-sectional area) were compared with healthy controls and their relation to walking distance and disease severity was investigated. Specific force was reduced by 14-49% in SBMA patients compared to healthy controls. Contractility was reduced by 22-39% in elbow flexion, knee extension, ankle dorsi- and plantarflexion in SBMA patients. The contractility decreased with increasing muscle fat content in muscles with affected contractility in SBMA. The decreased muscle contractility in SBMA may relate to motor neuron degeneration and changed fibre type distribution and muscle architecture.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dahlqvist</LastName><ForeName>Julia R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-3149-1661</Identifier><AffiliationInfo><Affiliation>Copenhagen Neuromuscular Center, section 3342 Department of Neurology, Rigshospitalet, University of Copenhagen Blegdamsvej 9, 2100, Copenhagen, Denmark. julia.rebecka.dahlqvist@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oestergaard</LastName><ForeName>Sofie T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Copenhagen Neuromuscular Center, section 3342 Department of Neurology, Rigshospitalet, University of Copenhagen Blegdamsvej 9, 2100, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulsen</LastName><ForeName>Nanna S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Copenhagen Neuromuscular Center, section 3342 Department of Neurology, Rigshospitalet, University of Copenhagen Blegdamsvej 9, 2100, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knak</LastName><ForeName>Kirsten Lykke</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Copenhagen Neuromuscular Center, section 3342 Department of Neurology, Rigshospitalet, University of Copenhagen Blegdamsvej 9, 2100, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomsen</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology, Rigshospitalet, University of Copenhagen Blegdamsvej 9, 2100, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vissing</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Copenhagen Neuromuscular Center, section 3342 Department of Neurology, Rigshospitalet, University of Copenhagen Blegdamsvej 9, 2100, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041321" MajorTopicYN="N">Chromosomes, Human, X</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009119" MajorTopicYN="N">Muscle Contraction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053581" MajorTopicYN="N">Muscle Strength Dynamometer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="N">Muscle Weakness</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>J. Vissing has received research and travel support, speaker honoraria from and/or served as consultant on advisory boards for Sanofi/Genzyme, Ultragenyx Pharmaceuticals, and Santhera Pharmaceuticals, Sarepta Therapeutics, Audentes Therapeutics, and Stealth Biotherapeutics. J. Dahlqvist reports no disclosures. S. Oestergaard reports no disclosures. N. Poulsen reports no disclosures. K. Knak reports no disclosures. C. Thomsen reports no disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30886222</ArticleId><ArticleId IdType="pmc">PMC6423126</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-41240-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-41240-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jordan CL, Lieberman AP. Spinal and bulbar muscular atrophy: a motoneuron or muscle disease? Curr. Opin. Pharmacol. 2008;8:752&#x2013;758. doi: 10.1016/j.coph.2008.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2008.08.006</ArticleId><ArticleId IdType="pmc">PMC2603477</ArticleId><ArticleId IdType="pubmed">18775514</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones EJ, Bishop PA, Woods AK, Green JM. Cross-sectional area and muscular strength: a brief review. Sports Med. Auckl. NZ. 2008;38:987&#x2013;994. doi: 10.2165/00007256-200838120-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00007256-200838120-00003</ArticleId><ArticleId IdType="pubmed">19026016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamano T, et al. Muscle MRI findings of X-linked spinal and bulbar muscular atrophy. J. Neurol. Sci. 2004;222:93&#x2013;97. doi: 10.1016/j.jns.2004.04.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2004.04.028</ArticleId><ArticleId IdType="pubmed">15240202</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Mishra A, Wakil S, Pennuto M, Soraru G. Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease) Amyotroph. Lateral Scler. Front. Degener. 2015;17:112&#x2013;118. doi: 10.3109/21678421.2015.1089910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1089910</ArticleId><ArticleId IdType="pubmed">26428534</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist, J. R., Oestergaard, S. T., Poulsen, N. S., Thomsen, C. &amp; Vissing, J. Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments. Neurology.92(6), e548&#x2013;59 (2019 Feb 5).</Citation><ArticleIdList><ArticleId IdType="pubmed">30610091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist JR, Vissing CR, Thomsen C, Vissing J. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy. Neurology. 2014;83:1178&#x2013;1183. doi: 10.1212/WNL.0000000000000828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000828</ArticleId><ArticleId IdType="pubmed">25142899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, et al. A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. Neuromuscul. Disord. NMD. 2015;25:554&#x2013;562. doi: 10.1016/j.nmd.2015.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2015.03.008</ArticleId><ArticleId IdType="pmc">PMC5608513</ArticleId><ArticleId IdType="pubmed">25913211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorentzen K, Danielsen MA, Kay SD, Voss A. Validation of the Fatigue Severity Scale in Danish patients with systemic lupus erythematosus. Dan. Med. J. 2014;61:A4808.</Citation><ArticleIdList><ArticleId IdType="pubmed">24814589</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31:1601&#x2013;1607. doi: 10.1093/sleep/31.11.1601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/31.11.1601</ArticleId><ArticleId IdType="pmc">PMC2579971</ArticleId><ArticleId IdType="pubmed">19014080</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa-de-Araujo R, et al. The Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report. Front. Physiol. 2017;8:87. doi: 10.3389/fphys.2017.00087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00087</ArticleId><ArticleId IdType="pmc">PMC5310167</ArticleId><ArticleId IdType="pubmed">28261109</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf8;kken N, Hedermann G, Thomsen C, Vissing J. Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I. Ann. Neurol. 2016;80:466&#x2013;471. doi: 10.1002/ana.24743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24743</ArticleId><ArticleId IdType="pubmed">27463532</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra RS, et al. Magnetic Resonance Assessment of Hypertrophic and Pseudo-Hypertrophic Changes in Lower Leg Muscles of Boys with Duchenne Muscular Dystrophy and Their Relationship to Functional Measurements. PloS One. 2015;10:e0128915. doi: 10.1371/journal.pone.0128915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128915</ArticleId><ArticleId IdType="pmc">PMC4477876</ArticleId><ArticleId IdType="pubmed">26103164</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulsen, N. S., Dahlqvist, J. R., Hedermann, G., L&#xf8;kken, N. &amp; Vissing, J. Muscle contractility of leg muscles in patients with mitochondrial myopathies. Mitochondrion, 10.1016/j.mito.2018.07.001 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30017555</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgia D, et al. Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients. Hum. Mol. Genet. 2017;26:1087&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409076</ArticleId><ArticleId IdType="pubmed">28087734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudora&#x15f;cu I, et al. Motor unit changes in normal aging: a brief review. Romanian J. Morphol. Embryol. Rev. Roum. Morphol. Embryol. 2014;55:1295&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pubmed">25611259</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus RL, et al. Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals. J. Aging Res. 2012;2012:629637. doi: 10.1155/2012/629637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/629637</ArticleId><ArticleId IdType="pmc">PMC3303569</ArticleId><ArticleId IdType="pubmed">22500231</ArticleId></ArticleIdList></Reference><Reference><Citation>Krivickas, L. S. et al. Age- and gender-related differences in maximum shortening velocity of skeletal muscle fibers. Am. J. Phys. Med. Rehabil. 80, 447&#x2013;455, quiz 456&#x2013;457 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11399006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A, et al. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. (Berl.) 2016;132:127&#x2013;144. doi: 10.1007/s00401-016-1550-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1550-4</ArticleId><ArticleId IdType="pmc">PMC4911374</ArticleId><ArticleId IdType="pubmed">26971100</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto Y, et al. Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 2013;124:1893&#x2013;1898. doi: 10.1016/j.clinph.2012.12.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2012.12.053</ArticleId><ArticleId IdType="pubmed">23643309</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K, et al. Muscular fatigue and decremental response to repetitive nerve stimulation in X-linked spinobulbar muscular atrophy. Eur. J. Neurol. 2009;16:76&#x2013;80. doi: 10.1111/j.1468-1331.2008.02349.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02349.x</ArticleId><ArticleId IdType="pubmed">19087153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorson CL, Rindt H, Shababi M. Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum. Mol. Genet. 2010;19:R111&#x2013;118. doi: 10.1093/hmg/ddq147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq147</ArticleId><ArticleId IdType="pmc">PMC2875050</ArticleId><ArticleId IdType="pubmed">20392710</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen, K. L. et al. Training improves oxidative capacity, but not function, in spinal muscular atrophy type III. Muscle Nerve, 10.1002/mus.24527 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25418505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma KR, Miller RG. Electrical and mechanical properties of skeletal muscle underlying increased fatigue in patients with amyotrophic lateral sclerosis. Muscle Nerve. 1996;19:1391&#x2013;1400. doi: 10.1002/(SICI)1097-4598(199611)19:11&lt;1391::AID-MUS3&gt;3.0.CO;2-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199611)19:11&lt;1391::AID-MUS3&gt;3.0.CO;2-7</ArticleId><ArticleId IdType="pubmed">8874396</ArticleId></ArticleIdList></Reference><Reference><Citation>Preisler N, et al. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease) Neurology. 2009;72:317&#x2013;323. doi: 10.1212/01.wnl.0000341274.61236.02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000341274.61236.02</ArticleId><ArticleId IdType="pubmed">19171827</ArticleId></ArticleIdList></Reference><Reference><Citation>Heje K, Andersen G, Vissing J. High intensity training in patients with spinal and bulbar muscular atrophy. Neuromuscul. Disord. 2015;25:S225. doi: 10.1016/j.nmd.2015.06.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2015.06.149</ArticleId><ArticleId IdType="pubmed">31004213</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>